Source comparison
What's the Half-Life of AOD-9604: Research Peptide Comparison
AOD-9604 30–60 minutes 2–4 hours Once daily (fasted) or pre-activity 28 days at 2–8°C Shortest half-life among common research peptides. Requires precise timing but clears system rapidly for washout studies BPC-157 4–6 hours 8–12 hours Twice daily (split dose)
This comparison does not assign a generated winner or score.
- AOD-9604
- 30–60 minutes
- 2–4 hours
- Once daily (fasted) or pre-activity
- 28 days at 2–8°C
- Shortest half-life among common research peptides. Requires precise timing but clears system rapidly for washout studies
- BPC-157
- 4–6 hours
- 8–12 hours
- Twice daily (split dose)
- Longer activity window allows flexible timing; gastric protection extends beyond plasma clearance
- CJC-1295 (DAC)
- 6–8 days
- Sustained elevation
- Once weekly
- Longest half-life in this group. Sustained GH pulse elevation across multiple days
- Ipamorelin
- 2 hours
- 3–5 hours
- 2–3 times daily
- Moderate half-life; multiple daily doses required for sustained GH response
- MOTS-C
- 60–90 minutes
- Once daily
- Similar clearance to AOD-9604 but mitochondrial effects persist longer than plasma presence
- AOD-9604's rapid clearance makes it ideal for research designs requiring short intervention windows or frequent washout periods between trials. Its lipolytic specificity. No growth hormone receptor activation, no IGF-1 elevation. Means it doesn't interfere with endocrine feedback loops the way longer-acting GH secretagogues do.